| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A4 COL12A1 CRELD2 SLIT2 FBLN2 FBN1 FBN2 HMCN2 VCAN COL14A1 MUC4 FBN3 | 1.96e-10 | 188 | 101 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | alpha1-adrenergic receptor activity | 1.26e-07 | 3 | 101 | 3 | GO:0004937 | |
| GeneOntologyMolecularFunction | calcium ion binding | NOTCH2NLA CRELD2 PLA2G2F ADGRE2 DLL1 NOTCH2NLC SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN FBN3 NOTCH2 | 2.02e-07 | 749 | 101 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | alpha-adrenergic receptor activity | 2.48e-06 | 6 | 101 | 3 | GO:0004936 | |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 1.47e-05 | 10 | 101 | 3 | GO:0004935 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.67e-05 | 12 | 101 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 4.39e-05 | 14 | 101 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A4 COL12A1 CRELD2 SLIT2 CRYGB FBLN2 FBN1 FBN2 HMCN2 VCAN COL14A1 KRTAP24-1 MUC4 FBN3 | 1.55e-04 | 891 | 101 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 5.14e-04 | 73 | 101 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 1.16e-03 | 41 | 101 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TRPV1 CHRNA9 OR4E2 ADGRE2 PLXNB2 ADRA1D ADRA1B ADRA1A HMCN2 EDAR ADGRE3 SEMA6A CHRNA10 ADGRL2 NOTCH2 SORL1 | 1.21e-03 | 1353 | 101 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.34e-03 | 43 | 101 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | Roundabout binding | 1.62e-03 | 12 | 101 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.63e-03 | 46 | 101 | 3 | GO:0030020 | |
| GeneOntologyBiologicalProcess | neuron-glial cell signaling | 1.20e-06 | 5 | 103 | 3 | GO:0150099 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 2.39e-06 | 6 | 103 | 3 | GO:0001978 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure by epinephrine-norepinephrine | 4.17e-06 | 7 | 103 | 3 | GO:0003321 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 6.65e-06 | 8 | 103 | 3 | GO:0001993 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by baroreceptor feedback | 6.65e-06 | 8 | 103 | 3 | GO:0003025 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 1.41e-05 | 10 | 103 | 3 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 1.41e-05 | 10 | 103 | 3 | GO:1902966 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | ELAPOR2 ZEB1 ZNF423 DLL1 SLIT2 FBN1 FBN2 SEMA6A NOTCH2 SORL1 | 4.10e-05 | 412 | 103 | 10 | GO:0090287 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to endosome | 4.23e-05 | 14 | 103 | 3 | GO:1905668 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 5.03e-05 | 80 | 103 | 5 | GO:2000179 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to endosome | 5.27e-05 | 15 | 103 | 3 | GO:1905666 | |
| GeneOntologyBiologicalProcess | protein localization to early endosome | 6.46e-05 | 16 | 103 | 3 | GO:1902946 | |
| GeneOntologyBiologicalProcess | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | 7.38e-05 | 3 | 103 | 2 | GO:0001994 | |
| GeneOntologyBiologicalProcess | baroreceptor response to increased systemic arterial blood pressure | 7.38e-05 | 3 | 103 | 2 | GO:0001983 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 8.90e-05 | 210 | 103 | 7 | GO:0007219 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.33e-04 | 224 | 103 | 7 | GO:0007204 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 1.42e-04 | 53 | 103 | 4 | GO:0045747 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.47e-04 | 4 | 103 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate by epinephrine-norepinephrine | 1.47e-04 | 4 | 103 | 2 | GO:0001996 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction by epinephrine-norepinephrine | 1.47e-04 | 4 | 103 | 2 | GO:0001997 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 1.69e-04 | 233 | 103 | 7 | GO:0061351 | |
| GeneOntologyBiologicalProcess | nervous system process involved in regulation of systemic arterial blood pressure | 2.27e-04 | 24 | 103 | 3 | GO:0001976 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction by chemical signal | 2.45e-04 | 5 | 103 | 2 | GO:0003099 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 2.57e-04 | 25 | 103 | 3 | GO:0071880 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3.96e-04 | 191 | 103 | 6 | GO:0007189 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 4.05e-04 | 269 | 103 | 7 | GO:0002064 | |
| GeneOntologyBiologicalProcess | negative regulation of heart contraction | 4.45e-04 | 30 | 103 | 3 | GO:0045822 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 5.09e-04 | 131 | 103 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | negative regulation of blood circulation | 5.40e-04 | 32 | 103 | 3 | GO:1903523 | |
| GeneOntologyBiologicalProcess | negative regulation of systemic arterial blood pressure | 5.40e-04 | 32 | 103 | 3 | GO:0003085 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 5.84e-04 | 286 | 103 | 7 | GO:0007188 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 5.84e-04 | 135 | 103 | 5 | GO:2000177 | |
| GeneOntologyBiologicalProcess | protein localization to endosome | 5.92e-04 | 33 | 103 | 3 | GO:0036010 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 6.78e-04 | 8 | 103 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | regulation of the force of heart contraction by chemical signal | 6.78e-04 | 8 | 103 | 2 | GO:0003057 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 7.05e-04 | 35 | 103 | 3 | GO:0071875 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A4 COL12A1 ZAN PLXNB2 SVEP1 SLIT2 FBLN2 FBN1 FBN2 IGFALS HMCN2 VCAN COL14A1 MUC4 FBN3 | 8.65e-07 | 656 | 104 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A4 COL12A1 ZAN PLXNB2 SVEP1 SLIT2 FBLN2 FBN1 FBN2 IGFALS HMCN2 VCAN COL14A1 MUC4 FBN3 | 8.98e-07 | 658 | 104 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | microfibril | 3.30e-05 | 13 | 104 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A4 COL12A1 PLXNB2 SLIT2 FBLN2 FBN1 FBN2 HMCN2 VCAN COL14A1 MUC4 | 6.67e-05 | 530 | 104 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | anchoring collagen complex | 7.33e-05 | 3 | 104 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | RAVE complex | 7.33e-05 | 3 | 104 | 2 | GO:0043291 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 3.63e-04 | 6 | 104 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | keratin filament | 1.41e-03 | 97 | 104 | 4 | GO:0045095 | |
| Domain | EGF_Ca-bd_CS | NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN FBN3 NOTCH2 | 8.60e-20 | 97 | 101 | 16 | IPR018097 |
| Domain | EGF_CA | NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN FBN3 NOTCH2 | 1.22e-19 | 99 | 101 | 16 | PS01187 |
| Domain | ASX_HYDROXYL | NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN FBN3 NOTCH2 | 1.44e-19 | 100 | 101 | 16 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN FBN3 NOTCH2 | 3.85e-19 | 106 | 101 | 16 | IPR000152 |
| Domain | EGF_3 | ZAN NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC PGAP6 SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN MUC4 FBN3 NOTCH2 SORL1 | 1.19e-18 | 235 | 101 | 20 | PS50026 |
| Domain | EGF | ZAN NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC PGAP6 SVEP1 RSPO3 SLIT2 FBLN2 FBN1 FBN2 EGF ADGRE3 VCAN MUC4 FBN3 NOTCH2 SORL1 | 1.19e-18 | 235 | 101 | 20 | SM00181 |
| Domain | EGF-like_dom | ZAN NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC PGAP6 SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN MUC4 FBN3 NOTCH2 SORL1 | 3.74e-18 | 249 | 101 | 20 | IPR000742 |
| Domain | EGF_CA | NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN FBN3 NOTCH2 | 4.01e-18 | 122 | 101 | 16 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 VCAN FBN3 NOTCH2 | 5.24e-18 | 124 | 101 | 16 | IPR001881 |
| Domain | EGF-like_CS | ZAN NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC PGAP6 SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF VCAN MUC4 FBN3 NOTCH2 SORL1 | 1.75e-16 | 261 | 101 | 19 | IPR013032 |
| Domain | EGF_2 | ZAN NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC PGAP6 SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF VCAN MUC4 FBN3 NOTCH2 SORL1 | 2.33e-16 | 265 | 101 | 19 | PS01186 |
| Domain | EGF_CA | NOTCH2NLA CRELD2 ADGRE2 NOTCH2NLC SVEP1 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 FBN3 NOTCH2 | 9.58e-16 | 86 | 101 | 13 | PF07645 |
| Domain | EGF_1 | ZAN NOTCH2NLA CRELD2 ADGRE2 DLL1 NOTCH2NLC PGAP6 SVEP1 SLIT2 FBLN2 FBN1 FBN2 HMCN2 EGF VCAN MUC4 FBN3 NOTCH2 | 2.02e-15 | 255 | 101 | 18 | PS00022 |
| Domain | Growth_fac_rcpt_ | ELAPOR2 CRELD2 ADGRE2 DLL1 SVEP1 RSPO3 FBLN2 FBN1 FBN2 HMCN2 EGF ADGRE3 ELAPOR1 FBN3 NOTCH2 | 5.44e-15 | 156 | 101 | 15 | IPR009030 |
| Domain | EGF | ZAN NOTCH2NLA DLL1 NOTCH2NLC SVEP1 SLIT2 EGF VCAN MUC4 FBN3 NOTCH2 | 8.05e-11 | 126 | 101 | 11 | PF00008 |
| Domain | hEGF | 7.36e-09 | 28 | 101 | 6 | PF12661 | |
| Domain | FBN | 1.53e-07 | 3 | 101 | 3 | IPR011398 | |
| Domain | TB | 5.29e-06 | 7 | 101 | 3 | PF00683 | |
| Domain | - | 8.43e-06 | 8 | 101 | 3 | 3.90.290.10 | |
| Domain | cEGF | 1.10e-05 | 26 | 101 | 4 | IPR026823 | |
| Domain | cEGF | 1.10e-05 | 26 | 101 | 4 | PF12662 | |
| Domain | TB | 1.26e-05 | 9 | 101 | 3 | PS51364 | |
| Domain | TB_dom | 1.26e-05 | 9 | 101 | 3 | IPR017878 | |
| Domain | - | DMXL2 DYNC2I2 BCAS3 PLXNB2 DDB1 DMXL1 TULP4 SEMA6A WDR90 BRWD1 | 1.30e-05 | 333 | 101 | 10 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DMXL2 DYNC2I2 BCAS3 PLXNB2 DDB1 DMXL1 TULP4 SEMA6A WDR90 BRWD1 | 1.37e-05 | 335 | 101 | 10 | IPR015943 |
| Domain | ADR_fam | 1.79e-05 | 10 | 101 | 3 | IPR002233 | |
| Domain | Rav1p_C | 2.90e-05 | 2 | 101 | 2 | IPR022033 | |
| Domain | Rav1p_C | 2.90e-05 | 2 | 101 | 2 | PF12234 | |
| Domain | AMOP | 1.73e-04 | 4 | 101 | 2 | SM00723 | |
| Domain | AMOP | 1.73e-04 | 4 | 101 | 2 | PF03782 | |
| Domain | AMOP_dom | 1.73e-04 | 4 | 101 | 2 | IPR005533 | |
| Domain | AMOP | 1.73e-04 | 4 | 101 | 2 | PS50856 | |
| Domain | WD40_repeat_dom | 2.09e-04 | 297 | 101 | 8 | IPR017986 | |
| Domain | Ephrin_rec_like | 3.24e-04 | 25 | 101 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.24e-04 | 25 | 101 | 3 | IPR011641 | |
| Domain | WD40 | 5.16e-04 | 259 | 101 | 7 | PF00400 | |
| Domain | WD40 | 6.32e-04 | 268 | 101 | 7 | SM00320 | |
| Domain | WD40_repeat | 6.90e-04 | 272 | 101 | 7 | IPR001680 | |
| Domain | WD_REPEATS_1 | 7.84e-04 | 278 | 101 | 7 | PS00678 | |
| Domain | Man6P_isomerase_rcpt-bd_dom | 7.94e-04 | 8 | 101 | 2 | IPR009011 | |
| Domain | WD_REPEATS_2 | 8.01e-04 | 279 | 101 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 8.01e-04 | 279 | 101 | 7 | PS50294 | |
| Domain | GPS | 8.13e-04 | 34 | 101 | 3 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 8.13e-04 | 34 | 101 | 3 | IPR017983 | |
| Domain | GPS | 8.86e-04 | 35 | 101 | 3 | PF01825 | |
| Domain | GPS | 9.63e-04 | 36 | 101 | 3 | PS50221 | |
| Domain | VWFA | 1.02e-03 | 82 | 101 | 4 | PS50234 | |
| Domain | GPS | 1.04e-03 | 37 | 101 | 3 | IPR000203 | |
| Domain | VWA | 1.12e-03 | 84 | 101 | 4 | SM00327 | |
| Domain | Keratin_B2_2 | 1.22e-03 | 39 | 101 | 3 | PF13885 | |
| Domain | Keratin_B2 | 1.31e-03 | 40 | 101 | 3 | PF01500 | |
| Domain | - | 1.54e-03 | 11 | 101 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 1.54e-03 | 11 | 101 | 2 | IPR023413 | |
| Domain | GAIN_dom_N | 1.54e-03 | 11 | 101 | 2 | IPR032471 | |
| Domain | GAIN | 1.54e-03 | 11 | 101 | 2 | PF16489 | |
| Domain | VWF_A | 2.05e-03 | 99 | 101 | 4 | IPR002035 | |
| Domain | PMG | 2.17e-03 | 13 | 101 | 2 | PF05287 | |
| Domain | KRTAP_PMG | 2.17e-03 | 13 | 101 | 2 | IPR007951 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.50e-03 | 50 | 101 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.50e-03 | 50 | 101 | 3 | PF00002 | |
| Domain | IMPORTIN_B_NT | 2.53e-03 | 14 | 101 | 2 | PS50166 | |
| Domain | Ldl_recept_b | 2.53e-03 | 14 | 101 | 2 | PF00058 | |
| Domain | LDLRB | 2.53e-03 | 14 | 101 | 2 | PS51120 | |
| Domain | IBN_N | 2.90e-03 | 15 | 101 | 2 | PF03810 | |
| Domain | LY | 2.90e-03 | 15 | 101 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.90e-03 | 15 | 101 | 2 | IPR000033 | |
| Domain | VWD | 3.31e-03 | 16 | 101 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.31e-03 | 16 | 101 | 2 | IPR001846 | |
| Domain | IBN_N | 3.31e-03 | 16 | 101 | 2 | SM00913 | |
| Domain | VWFD | 3.31e-03 | 16 | 101 | 2 | PS51233 | |
| Domain | Nicotinic_acetylcholine_rcpt | 3.31e-03 | 16 | 101 | 2 | IPR002394 | |
| Domain | VWD | 3.31e-03 | 16 | 101 | 2 | PF00094 | |
| Domain | VWA | 3.46e-03 | 56 | 101 | 3 | PF00092 | |
| Domain | Importin-beta_N | 3.73e-03 | 17 | 101 | 2 | IPR001494 | |
| Domain | Laminin_G | 3.82e-03 | 58 | 101 | 3 | IPR001791 | |
| Domain | KAP | 3.82e-03 | 58 | 101 | 3 | IPR002494 | |
| Domain | Furin_repeat | 4.19e-03 | 18 | 101 | 2 | IPR006212 | |
| Domain | FU | 4.19e-03 | 18 | 101 | 2 | SM00261 | |
| Domain | GPCR_2_secretin-like | 4.20e-03 | 60 | 101 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.20e-03 | 60 | 101 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.40e-03 | 61 | 101 | 3 | PS50261 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 7.71e-06 | 25 | 73 | 4 | M39713 | |
| Pathway | REACTOME_ADRENOCEPTORS | 1.09e-05 | 9 | 73 | 3 | M27302 | |
| Pathway | REACTOME_ADRENOCEPTORS | 1.09e-05 | 9 | 73 | 3 | MM15009 | |
| Pathway | WP_PRIMARY_OVARIAN_INSUFFICIENCY | 3.18e-05 | 174 | 73 | 7 | M48058 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.84e-05 | 37 | 73 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.68e-05 | 44 | 73 | 4 | M26969 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.49e-05 | 140 | 73 | 6 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.55e-04 | 300 | 73 | 8 | M610 | |
| Pathway | REACTOME_ACETYLCHOLINE_INHIBITS_CONTRACTION_OF_OUTER_HAIR_CELLS | 2.62e-04 | 5 | 73 | 2 | M41824 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.69e-04 | 258 | 73 | 7 | MM14572 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 5.07e-04 | 272 | 73 | 7 | M13380 | |
| Pathway | WP_MONOAMINE_GPCRS | 5.40e-04 | 31 | 73 | 3 | MM15871 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 5.46e-04 | 7 | 73 | 2 | M47805 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.93e-04 | 32 | 73 | 3 | MM14854 | |
| Pathway | WP_MONOAMINE_GPCRS | 6.50e-04 | 33 | 73 | 3 | M39585 | |
| Pubmed | COL4A4 COL12A1 CRELD2 PLXNB2 SLIT2 FBLN2 FBN1 FBN2 HMCN2 COL14A1 MUC4 | 5.67e-12 | 175 | 104 | 11 | 28071719 | |
| Pubmed | Gene expressions and mechanical functions of α1-adrenoceptor subtypes in mouse ureter. | 2.60e-08 | 3 | 104 | 3 | 19259685 | |
| Pubmed | Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. | 2.60e-08 | 3 | 104 | 3 | 17973108 | |
| Pubmed | Examination of alpha 1 adrenoceptor subtypes in the human ureter. | 2.60e-08 | 3 | 104 | 3 | 17681068 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 7595531 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 12595294 | ||
| Pubmed | Functional role of α1-adrenoceptor subtypes in murine ophthalmic arteries. | 2.60e-08 | 3 | 104 | 3 | 21613371 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 29089212 | ||
| Pubmed | Role of α1-adrenoceptor subtypes on corneal epithelial thickness and cell proliferation in mice. | 2.60e-08 | 3 | 104 | 3 | 30257104 | |
| Pubmed | Differential regulation of the cell cycle by alpha1-adrenergic receptor subtypes. | 2.60e-08 | 3 | 104 | 3 | 15297446 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 8183249 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 17384126 | ||
| Pubmed | Role of α₁-adrenoceptor subtypes in pupil dilation studied with gene-targeted mice. | 2.60e-08 | 3 | 104 | 3 | 25425303 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 8024574 | ||
| Pubmed | Alpha1-adrenoceptors are required for normal male sexual function. | 2.60e-08 | 3 | 104 | 3 | 17603545 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 14659805 | ||
| Pubmed | The presence and distribution of alpha adrenergic receptors in human renal pelvis and calyces. | 2.60e-08 | 3 | 104 | 3 | 23877383 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 7815325 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 18257748 | ||
| Pubmed | Specific interactions between gC1qR and alpha1-adrenoceptor subtypes. | 2.60e-08 | 3 | 104 | 3 | 14626446 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 10493741 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 12409310 | ||
| Pubmed | 4.16e-08 | 167 | 104 | 8 | 22159717 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.04e-07 | 4 | 104 | 3 | 25034023 | |
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 1.04e-07 | 4 | 104 | 3 | 32330268 | |
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 32085899 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.39e-07 | 86 | 104 | 6 | 28327460 | |
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 24844469 | ||
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 2.59e-07 | 5 | 104 | 3 | 29856954 | |
| Pubmed | Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. | 2.59e-07 | 5 | 104 | 3 | 29856955 | |
| Pubmed | 4.13e-07 | 50 | 104 | 5 | 23658023 | ||
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 12184796 | ||
| Pubmed | Yeast two-hybrid screening for proteins that interact with alpha1-adrenergic receptors. | 5.16e-07 | 6 | 104 | 3 | 15525470 | |
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 28862946 | ||
| Pubmed | Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes. | 5.16e-07 | 6 | 104 | 3 | 17636168 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FLNA ZNF423 NOTCH2NLA CRELD2 DDB1 SLIT2 FBLN2 FBN1 MPND FHL3 NOTCH2 | 9.89e-07 | 560 | 104 | 11 | 21653829 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA SLC37A3 BCAS3 DLL1 PLXNB2 ZNF865 FANCA PIAS4 FASN TULP4 NEK8 DUSP16 HMGXB3 WDR90 NOTCH2 | 1.05e-06 | 1105 | 104 | 15 | 35748872 |
| Pubmed | 1.26e-06 | 27 | 104 | 4 | 32878924 | ||
| Pubmed | Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. | 1.44e-06 | 8 | 104 | 3 | 9139936 | |
| Pubmed | An ultra-high sulfur keratin gene is expressed specifically during hair growth. | 1.44e-06 | 8 | 104 | 3 | 2465353 | |
| Pubmed | 2.09e-06 | 69 | 104 | 5 | 18721477 | ||
| Pubmed | Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. | 2.15e-06 | 9 | 104 | 3 | 21209093 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A4 COL12A1 B4GAT1 CRELD2 CPD ADGRE2 PLXNB2 DDB1 DMXL1 FANCA FBN1 FBN2 TBC1D4 NOTCH2 SORL1 | 2.92e-06 | 1201 | 104 | 15 | 35696571 |
| Pubmed | 3.07e-06 | 10 | 104 | 3 | 21063774 | ||
| Pubmed | 5.34e-06 | 146 | 104 | 6 | 27068509 | ||
| Pubmed | 6.23e-06 | 86 | 104 | 5 | 35103284 | ||
| Pubmed | 6.99e-06 | 153 | 104 | 6 | 25037231 | ||
| Pubmed | 7.27e-06 | 13 | 104 | 3 | 26531127 | ||
| Pubmed | 8.51e-06 | 43 | 104 | 4 | 24227653 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12399449 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17283256 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21851253 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15609093 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 9886271 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 8.86e-06 | 2 | 104 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 8.86e-06 | 2 | 104 | 2 | 21440062 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15131124 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28223528 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25481381 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 8.86e-06 | 2 | 104 | 2 | 20404337 | |
| Pubmed | Clinical implications from studies of alpha1 adrenergic receptor knockout mice. | 8.86e-06 | 2 | 104 | 2 | 17141736 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 14736874 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 8.86e-06 | 2 | 104 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 8.86e-06 | 2 | 104 | 2 | 8307578 | |
| Pubmed | Nicotinic acetylcholine receptors regulate vestibular afferent gain and activation timing. | 8.86e-06 | 2 | 104 | 2 | 27718229 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18077337 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 38178640 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 8.86e-06 | 2 | 104 | 2 | 7744963 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26408953 | ||
| Pubmed | A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit. | 8.86e-06 | 2 | 104 | 2 | 11752216 | |
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 8.86e-06 | 2 | 104 | 2 | 18006876 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 11726670 | ||
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 8.86e-06 | 2 | 104 | 2 | 24833718 | |
| Pubmed | Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. | 8.86e-06 | 2 | 104 | 2 | 8702639 | |
| Pubmed | Deletion of nicotinic acetylcholine receptor alpha9 in mice resulted in altered bone structure. | 8.86e-06 | 2 | 104 | 2 | 30414510 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23963449 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17960519 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19166271 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24265020 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 20529844 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 9451590 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23133647 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10860850 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18802028 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 27349288 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 8.86e-06 | 2 | 104 | 2 | 1852206 | |
| Pubmed | Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA. | 8.86e-06 | 2 | 104 | 2 | 22774872 | |
| Pubmed | Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. | 8.86e-06 | 2 | 104 | 2 | 9298975 | |
| Pubmed | The mouse tight skin (Tsk) phenotype is not dependent on the presence of mature T and B lymphocytes. | 8.86e-06 | 2 | 104 | 2 | 9799844 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10820200 | ||
| Pubmed | Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. | 8.86e-06 | 2 | 104 | 2 | 16585965 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12429739 | ||
| Pubmed | Characterization of HA-tagged α9 and α10 nAChRs in the mouse cochlea. | 8.86e-06 | 2 | 104 | 2 | 33311584 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 14660750 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12888550 | ||
| Pubmed | Abnormal corneal endothelial maturation in collagen XII and XIV null mice. | 8.86e-06 | 2 | 104 | 2 | 23599329 | |
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 8.86e-06 | 2 | 104 | 2 | 12524050 | |
| Pubmed | Transportin-1 and Transportin-2: protein nuclear import and beyond. | 8.86e-06 | 2 | 104 | 2 | 24780099 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19540213 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12782680 | ||
| Interaction | ZFP41 interactions | 4.02e-07 | 57 | 101 | 6 | int:ZFP41 | |
| Interaction | FBN1 interactions | 5.60e-06 | 51 | 101 | 5 | int:FBN1 | |
| Interaction | NTN5 interactions | 5.85e-06 | 24 | 101 | 4 | int:NTN5 | |
| Interaction | SLURP1 interactions | 8.07e-06 | 144 | 101 | 7 | int:SLURP1 | |
| Interaction | ZNF408 interactions | 8.44e-06 | 145 | 101 | 7 | int:ZNF408 | |
| Interaction | HOXA1 interactions | ZBTB16 KRTAP9-4 KRTAP13-2 NOTCH2NLA CRELD2 SLIT2 FBLN2 FBN1 KRTAP9-2 FHL3 | 1.21e-05 | 356 | 101 | 10 | int:HOXA1 |
| Interaction | FBLN2 interactions | 2.01e-05 | 66 | 101 | 5 | int:FBLN2 | |
| Interaction | FBXO2 interactions | COL12A1 CPD PLXNB2 SLIT2 FBN1 FBN2 COL14A1 SEMA6A NOTCH2 SORL1 | 4.11e-05 | 411 | 101 | 10 | int:FBXO2 |
| Interaction | DCN interactions | 6.31e-05 | 43 | 101 | 4 | int:DCN | |
| Interaction | GIP interactions | 6.92e-05 | 44 | 101 | 4 | int:GIP | |
| Interaction | ST14 interactions | 8.29e-05 | 207 | 101 | 7 | int:ST14 | |
| Interaction | LTBP1 interactions | 9.96e-05 | 92 | 101 | 5 | int:LTBP1 | |
| Interaction | ADAMTSL4 interactions | 1.11e-04 | 217 | 101 | 7 | int:ADAMTSL4 | |
| Interaction | CCN6 interactions | 1.12e-04 | 19 | 101 | 3 | int:CCN6 | |
| GeneFamily | Adrenoceptors | 4.59e-06 | 9 | 70 | 3 | 169 | |
| GeneFamily | Keratin associated proteins | 6.44e-05 | 109 | 70 | 5 | 619 | |
| GeneFamily | WD repeat domain containing | 6.82e-05 | 262 | 70 | 7 | 362 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 1.47e-04 | 5 | 70 | 2 | 915 | |
| GeneFamily | Fibulins | 4.08e-04 | 8 | 70 | 2 | 556 | |
| GeneFamily | Collagens | 7.49e-04 | 46 | 70 | 3 | 490 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.50e-03 | 15 | 70 | 2 | 529 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.71e-03 | 16 | 70 | 2 | 173 | |
| GeneFamily | Armadillo repeat containing|Importins | 2.17e-03 | 18 | 70 | 2 | 596 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A4 COL12A1 CRELD2 SVEP1 RSPO3 SLIT2 FBLN2 FBN1 FBN2 IGFALS HMCN2 VCAN COL14A1 FBN3 | 3.67e-12 | 275 | 102 | 14 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL4A4 COL12A1 CRELD2 SVEP1 RSPO3 SLIT2 FBLN2 FBN1 FBN2 IGFALS HMCN2 VCAN COL14A1 | 4.56e-11 | 270 | 102 | 13 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.09e-09 | 196 | 102 | 10 | M3008 | |
| Coexpression | NABA_MATRISOME | COL4A4 COL12A1 ISM1 CRELD2 PLXNB2 SVEP1 RSPO3 SLIT2 FBLN2 FBN1 FBN2 IGFALS HMCN2 EGF ADAM5 VCAN COL14A1 SEMA6A MUC4 | 1.08e-08 | 1008 | 102 | 19 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A4 COL12A1 ISM1 CRELD2 PLXNB2 SVEP1 RSPO3 SLIT2 FBLN2 FBN1 FBN2 IGFALS HMCN2 EGF VCAN COL14A1 SEMA6A MUC4 FBN3 | 1.43e-08 | 1026 | 102 | 19 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.13e-08 | 191 | 102 | 9 | MM17059 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.19e-06 | 200 | 102 | 8 | M5930 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.63e-05 | 137 | 102 | 6 | M40313 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 7.08e-05 | 178 | 102 | 6 | M17079 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 7.40e-05 | 261 | 102 | 7 | M1834 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.05e-04 | 276 | 102 | 7 | M3063 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN | 1.07e-04 | 192 | 102 | 6 | M4277 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.07e-04 | 479 | 102 | 9 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.14e-04 | 483 | 102 | 9 | MM1082 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | 1.24e-04 | 197 | 102 | 6 | M8686 | |
| Coexpression | GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP | 1.34e-04 | 200 | 102 | 6 | M8051 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 1.34e-04 | 200 | 102 | 6 | M4948 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.54e-04 | 69 | 102 | 4 | M10165 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.56e-04 | 27 | 102 | 3 | M47994 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K4 | 1.59e-06 | 81 | 94 | 6 | facebase_RNAseq_e10.5_MandArch_2500_K4 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.09e-05 | 261 | 94 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | FLNA PLXNB2 SVEP1 SLIT2 FBLN2 FBN1 FBN2 VCAN COL14A1 SEMA6A SPIDR ADGRL2 NOTCH2 | 7.05e-05 | 827 | 94 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | 8.71e-05 | 411 | 94 | 9 | GSM854302_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 9.90e-05 | 418 | 94 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.97e-10 | 185 | 103 | 9 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.60e-10 | 191 | 103 | 9 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.23e-10 | 193 | 103 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 7.57e-10 | 194 | 103 | 9 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.57e-10 | 194 | 103 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.92e-10 | 195 | 103 | 9 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.92e-10 | 195 | 103 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.92e-10 | 195 | 103 | 9 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.92e-10 | 195 | 103 | 9 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.90e-10 | 200 | 103 | 9 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.90e-10 | 200 | 103 | 9 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.90e-10 | 200 | 103 | 9 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.18e-09 | 149 | 103 | 8 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-08 | 185 | 103 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.30e-08 | 187 | 103 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-08 | 188 | 103 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.47e-08 | 190 | 103 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-08 | 192 | 103 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-08 | 192 | 103 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-08 | 192 | 103 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.60e-08 | 192 | 103 | 8 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.60e-08 | 192 | 103 | 8 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.66e-08 | 193 | 103 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.73e-08 | 194 | 103 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.80e-08 | 195 | 103 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 1.95e-08 | 197 | 103 | 8 | 9a053a32ff9c3a85ef9a3382453acd619cc48546 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.20e-08 | 200 | 103 | 8 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-08 | 200 | 103 | 8 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-08 | 200 | 103 | 8 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.20e-08 | 200 | 103 | 8 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-08 | 200 | 103 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-08 | 200 | 103 | 8 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-08 | 200 | 103 | 8 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-08 | 200 | 103 | 8 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-08 | 200 | 103 | 8 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.36e-07 | 169 | 103 | 7 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-07 | 171 | 103 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-07 | 172 | 103 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-07 | 175 | 103 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-07 | 178 | 103 | 7 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-07 | 178 | 103 | 7 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-07 | 187 | 103 | 7 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-07 | 187 | 103 | 7 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-07 | 187 | 103 | 7 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-07 | 187 | 103 | 7 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-07 | 188 | 103 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.02e-07 | 190 | 103 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-07 | 190 | 103 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-07 | 191 | 103 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-07 | 191 | 103 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.24e-07 | 192 | 103 | 7 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.24e-07 | 192 | 103 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.24e-07 | 192 | 103 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-07 | 193 | 103 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.35e-07 | 193 | 103 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-07 | 193 | 103 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.47e-07 | 194 | 103 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-07 | 194 | 103 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.47e-07 | 194 | 103 | 7 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-07 | 194 | 103 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-07 | 195 | 103 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-07 | 195 | 103 | 7 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-07 | 195 | 103 | 7 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.60e-07 | 195 | 103 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.60e-07 | 195 | 103 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-07 | 196 | 103 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-07 | 196 | 103 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.72e-07 | 196 | 103 | 7 | 988a3e0688e0a7ba69774497d3b130631bb26c50 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-07 | 197 | 103 | 7 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-07 | 197 | 103 | 7 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-07 | 197 | 103 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-07 | 197 | 103 | 7 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.85e-07 | 197 | 103 | 7 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.99e-07 | 198 | 103 | 7 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.99e-07 | 198 | 103 | 7 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 3.99e-07 | 198 | 103 | 7 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-07 | 198 | 103 | 7 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.99e-07 | 198 | 103 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.99e-07 | 198 | 103 | 7 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.12e-07 | 199 | 103 | 7 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-07 | 199 | 103 | 7 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 4.12e-07 | 199 | 103 | 7 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-07 | 199 | 103 | 7 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-07 | 199 | 103 | 7 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-07 | 199 | 103 | 7 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.12e-07 | 199 | 103 | 7 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 4.12e-07 | 199 | 103 | 7 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-07 | 199 | 103 | 7 | 8d71e1fc92ee24deedf23fbb1a85a7fba0d8d436 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.12e-07 | 199 | 103 | 7 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 4.12e-07 | 199 | 103 | 7 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 4.12e-07 | 199 | 103 | 7 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-07 | 199 | 103 | 7 | 49690494270981eec5b5261c59e0545dff90cc21 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-07 | 199 | 103 | 7 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.12e-07 | 199 | 103 | 7 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.12e-07 | 199 | 103 | 7 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-07 | 200 | 103 | 7 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.26e-07 | 200 | 103 | 7 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-07 | 200 | 103 | 7 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-07 | 200 | 103 | 7 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 200 | 103 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| Drug | 1-(2-(3-methoxyphenyl)ethyl)phenoxy-3-(dimethylamino)-2-propanol | 8.73e-08 | 3 | 102 | 3 | ctd:C099060 | |
| Drug | Alfuzosin | 8.73e-08 | 3 | 102 | 3 | DB00346 | |
| Drug | Phenylephrine | 8.73e-08 | 3 | 102 | 3 | DB00388 | |
| Drug | Dapiprazole | 8.73e-08 | 3 | 102 | 3 | DB00298 | |
| Drug | 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone | 8.73e-08 | 3 | 102 | 3 | ctd:C048008 | |
| Drug | Tamsulosin | 8.73e-08 | 3 | 102 | 3 | DB00706 | |
| Drug | abanoquil | 8.73e-08 | 3 | 102 | 3 | ctd:C058534 | |
| Drug | ifoxetine | 8.73e-08 | 3 | 102 | 3 | CID000071971 | |
| Drug | chlorethylclonidine | 8.73e-08 | 3 | 102 | 3 | ctd:C051731 | |
| Drug | Wy 25309 | 8.73e-08 | 3 | 102 | 3 | CID000133818 | |
| Drug | XB513 | 8.73e-08 | 3 | 102 | 3 | CID000183813 | |
| Drug | tamsulosin | 3.48e-07 | 4 | 102 | 3 | ctd:C088482 | |
| Drug | sertindole | 3.48e-07 | 4 | 102 | 3 | ctd:C066304 | |
| Drug | BE 2254 | 3.48e-07 | 4 | 102 | 3 | ctd:C010652 | |
| Drug | 5-methylurapidil | 3.48e-07 | 4 | 102 | 3 | ctd:C057446 | |
| Drug | Leniquinsin | 8.67e-07 | 5 | 102 | 3 | CID000025195 | |
| Drug | AC1L9NP0 | 8.67e-07 | 5 | 102 | 3 | CID000449842 | |
| Drug | S-10089 | 8.67e-07 | 5 | 102 | 3 | CID000146399 | |
| Drug | CS-263 | 8.67e-07 | 5 | 102 | 3 | CID000137303 | |
| Drug | 5-methylgramine | 8.67e-07 | 5 | 102 | 3 | CID000034855 | |
| Drug | metazosin | 8.67e-07 | 5 | 102 | 3 | CID000093514 | |
| Drug | AC1O6ABX | 8.67e-07 | 5 | 102 | 3 | CID006449894 | |
| Drug | KABI 2023 | 8.67e-07 | 5 | 102 | 3 | CID000192124 | |
| Drug | A-53693 | 8.67e-07 | 5 | 102 | 3 | CID003082713 | |
| Drug | methylatropine | 9.50e-07 | 40 | 102 | 5 | CID000005860 | |
| Drug | tripelennamine | 1.22e-06 | 42 | 102 | 5 | CID000005587 | |
| Drug | Doxazosin | 1.73e-06 | 6 | 102 | 3 | DB00590 | |
| Drug | Prazosin | 1.73e-06 | 6 | 102 | 3 | DB00457 | |
| Drug | Br-pindolol | 1.73e-06 | 6 | 102 | 3 | CID000125847 | |
| Drug | Terazosin | 1.73e-06 | 6 | 102 | 3 | DB01162 | |
| Drug | Terazosin | 1.73e-06 | 6 | 102 | 3 | ctd:C041226 | |
| Drug | BMY 7378 | 1.73e-06 | 6 | 102 | 3 | ctd:C053428 | |
| Drug | Xylometazoline | 1.73e-06 | 6 | 102 | 3 | DB06694 | |
| Drug | alfuzosin | 1.73e-06 | 6 | 102 | 3 | ctd:C047638 | |
| Drug | dibozane | 1.73e-06 | 6 | 102 | 3 | CID000094342 | |
| Drug | Naphazoline | 3.02e-06 | 7 | 102 | 3 | ctd:D009278 | |
| Drug | xylometazoline | 3.02e-06 | 7 | 102 | 3 | ctd:C009695 | |
| Drug | Epinephrine | 4.81e-06 | 8 | 102 | 3 | DB00668 | |
| Drug | Oxymetazoline | 4.81e-06 | 8 | 102 | 3 | ctd:D010109 | |
| Drug | tiodazosin | 4.81e-06 | 8 | 102 | 3 | CID000060891 | |
| Drug | Sertindole | 4.81e-06 | 8 | 102 | 3 | DB06144 | |
| Drug | dibenamine | 5.26e-06 | 26 | 102 | 4 | CID000005820 | |
| Drug | alpha-methyldopamine | 5.26e-06 | 26 | 102 | 4 | CID000017005 | |
| Drug | guanadrel | 7.19e-06 | 9 | 102 | 3 | CID000038521 | |
| Drug | SB-273779 | 7.19e-06 | 9 | 102 | 3 | CID005311133 | |
| Drug | dapiprazole | 7.19e-06 | 9 | 102 | 3 | CID003033538 | |
| Drug | p-menthane | 7.19e-06 | 9 | 102 | 3 | CID000007459 | |
| Drug | adrafinil | 7.19e-06 | 9 | 102 | 3 | CID003033226 | |
| Drug | Norepinephrine | 1.02e-05 | 10 | 102 | 3 | DB00368 | |
| Drug | trimazosin | 1.02e-05 | 10 | 102 | 3 | CID000037264 | |
| Drug | L-659,066 | 1.02e-05 | 10 | 102 | 3 | CID000163952 | |
| Drug | Ergotamine | 1.02e-05 | 10 | 102 | 3 | DB00696 | |
| Drug | azapetine | 1.02e-05 | 10 | 102 | 3 | CID000008966 | |
| Drug | Droxidopa | 1.02e-05 | 10 | 102 | 3 | DB06262 | |
| Drug | DO 710 | 1.02e-05 | 10 | 102 | 3 | CID003084985 | |
| Drug | bethanidine | 1.86e-05 | 12 | 102 | 3 | CID000002368 | |
| Drug | SZL-49 | 1.86e-05 | 12 | 102 | 3 | CID000004892 | |
| Drug | St-1913 | 1.99e-05 | 2 | 102 | 2 | CID000123528 | |
| Drug | Neldazosin | 1.99e-05 | 2 | 102 | 2 | CID000065908 | |
| Drug | DL-028 | 1.99e-05 | 2 | 102 | 2 | CID005487531 | |
| Drug | quinazosin | 1.99e-05 | 2 | 102 | 2 | CID000027486 | |
| Drug | hydroxyphenacetyl aminoclonidine | 1.99e-05 | 2 | 102 | 2 | CID000173558 | |
| Drug | Midodrine | 1.99e-05 | 2 | 102 | 2 | DB00211 | |
| Drug | sulfonterol | 1.99e-05 | 2 | 102 | 2 | CID000170372 | |
| Drug | AC1L27FT | 1.99e-05 | 2 | 102 | 2 | CID000016192 | |
| Drug | paveril | 1.99e-05 | 2 | 102 | 2 | CID000006855 | |
| Drug | tolazine | 1.99e-05 | 2 | 102 | 2 | CID000101252 | |
| Drug | piclonidine | 1.99e-05 | 2 | 102 | 2 | CID000068914 | |
| Drug | Lidanserin | 1.99e-05 | 2 | 102 | 2 | CID000068919 | |
| Drug | FCE 22716 | 1.99e-05 | 2 | 102 | 2 | CID000125720 | |
| Drug | SKF 101253 | 1.99e-05 | 2 | 102 | 2 | CID000135152 | |
| Drug | ASL-7022 | 1.99e-05 | 2 | 102 | 2 | CID000173406 | |
| Drug | hoquizil | 1.99e-05 | 2 | 102 | 2 | CID000030690 | |
| Drug | Methoxamine | 1.99e-05 | 2 | 102 | 2 | DB00723 | |
| Drug | Prestwick_774 | 1.99e-05 | 2 | 102 | 2 | CID006420011 | |
| Drug | compound 44-549 | 1.99e-05 | 2 | 102 | 2 | CID000191431 | |
| Drug | 5-dembs | 1.99e-05 | 2 | 102 | 2 | CID000130379 | |
| Drug | levomepromazine sulfoxide | 1.99e-05 | 2 | 102 | 2 | CID000165566 | |
| Drug | R 56 | 1.99e-05 | 2 | 102 | 2 | CID009578362 | |
| Drug | dihydrolysergic acid amide | 1.99e-05 | 2 | 102 | 2 | CID000151000 | |
| Drug | St-404 | 1.99e-05 | 2 | 102 | 2 | CID000191786 | |
| Drug | AC1MBW4N | 1.99e-05 | 2 | 102 | 2 | CID002732234 | |
| Drug | Myordil | 1.99e-05 | 2 | 102 | 2 | CID000011282 | |
| Drug | 5-cfmbs | 1.99e-05 | 2 | 102 | 2 | CID000183818 | |
| Drug | IK29 | 1.99e-05 | 2 | 102 | 2 | CID000183825 | |
| Drug | pyrroxan | 1.99e-05 | 2 | 102 | 2 | CID000036302 | |
| Drug | dihydroergonine | 1.99e-05 | 2 | 102 | 2 | CID000193205 | |
| Drug | Indoramin | 1.99e-05 | 2 | 102 | 2 | ctd:D007217 | |
| Drug | penta-O-ethylquercetin | 1.99e-05 | 2 | 102 | 2 | CID000133942 | |
| Drug | sarpogrelate | 2.24e-05 | 37 | 102 | 4 | ctd:C064294 | |
| Drug | practolol | 2.24e-05 | 37 | 102 | 4 | CID000004883 | |
| Drug | NSC196867 | 2.42e-05 | 13 | 102 | 3 | CID000003982 | |
| Drug | indoramin | 2.42e-05 | 13 | 102 | 3 | CID000033625 | |
| Drug | oxymetazoline | 2.83e-05 | 79 | 102 | 5 | CID000004636 | |
| Drug | DMSe | 2.89e-05 | 132 | 102 | 6 | CID000020796 | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 1158_UP | |
| Drug | Estriol [50-27-1]; Up 200; 13.8uM; PC3; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 5866_UP | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 7217_UP | |
| Drug | deriglidole | 3.07e-05 | 14 | 102 | 3 | CID000065945 | |
| Drug | propiomazine | 3.07e-05 | 14 | 102 | 3 | CID000004940 | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.23e-08 | 3 | 95 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0081262 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.62e-05 | 53 | 95 | 4 | C4707243 | |
| Disease | Bicuspid aortic valve | 3.07e-05 | 3 | 95 | 2 | HP_0001647 | |
| Disease | Malignant neoplasm of breast | FLNA ZEB1 B4GAT1 DTX3L DLL1 RSPO3 FASN ADRA1A EGF STPG1 ELAPOR1 NOTCH2 SORL1 | 4.02e-05 | 1074 | 95 | 13 | C0006142 |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 4.12e-05 | 21 | 95 | 3 | DOID:11612 (biomarker_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 6.13e-05 | 4 | 95 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | response to hydroxyurea | 6.13e-05 | 4 | 95 | 2 | GO_0072710 | |
| Disease | levulinate 4-oxovalerate measurement | 6.13e-05 | 4 | 95 | 2 | EFO_0021024 | |
| Disease | cortical surface area measurement | ZBTB16 ZAN ZNF423 SKIDA1 PLXNB2 SVEP1 RSPO3 SLIT2 FBN1 FBN2 VCAN SEMA6A ADGRL2 FBN3 | 1.01e-04 | 1345 | 95 | 14 | EFO_0010736 |
| Disease | Metaplasia | 1.02e-04 | 5 | 95 | 2 | C0025568 | |
| Disease | response to angiotensin receptor blocker | 1.23e-04 | 30 | 95 | 3 | EFO_0010735 | |
| Disease | Fever, Diarrhea, response to sulfasalazine | 1.53e-04 | 6 | 95 | 2 | EFO_0008324, HP_0001945, HP_0002014 | |
| Disease | birth measurement, spontaneous preterm birth | 2.13e-04 | 7 | 95 | 2 | EFO_0006917, EFO_0006921 | |
| Disease | NEPHRONOPHTHISIS 2 | 2.84e-04 | 8 | 95 | 2 | C1865872 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 2.84e-04 | 8 | 95 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 2.99e-04 | 525 | 95 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.99e-04 | 525 | 95 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 3.06e-04 | 527 | 95 | 8 | C1458155 | |
| Disease | brain connectivity measurement | 3.17e-04 | 400 | 95 | 7 | EFO_0005210 | |
| Disease | Neoplasm Invasiveness | 3.29e-04 | 184 | 95 | 5 | C0027626 | |
| Disease | Breast Carcinoma | 3.52e-04 | 538 | 95 | 8 | C0678222 | |
| Disease | mitral valve prolapse (is_implicated_in) | 3.64e-04 | 9 | 95 | 2 | DOID:988 (is_implicated_in) | |
| Disease | grey matter volume measurement | 3.89e-04 | 44 | 95 | 3 | EFO_0005420 | |
| Disease | serum urea measurement | 4.29e-04 | 195 | 95 | 5 | EFO_0009795 | |
| Disease | dimethylglycine measurement | 4.44e-04 | 46 | 95 | 3 | EFO_0010476 | |
| Disease | blood urea nitrogen measurement | 6.55e-04 | 452 | 95 | 7 | EFO_0004741 | |
| Disease | Tinnitus, response to cisplatin | 1.05e-03 | 15 | 95 | 2 | GO_0072718, HP_0000360 | |
| Disease | Neoplastic Cell Transformation | 1.08e-03 | 139 | 95 | 4 | C0007621 | |
| Disease | Liver carcinoma | 1.28e-03 | 507 | 95 | 7 | C2239176 | |
| Disease | S-adenosylhomocysteine measurement | 1.35e-03 | 17 | 95 | 2 | EFO_0010531 | |
| Disease | amino acid measurement | 1.57e-03 | 678 | 95 | 8 | EFO_0005134 | |
| Disease | abnormal paneth cell measurement | 1.69e-03 | 19 | 95 | 2 | EFO_0007963 | |
| Disease | ovulation | 1.69e-03 | 19 | 95 | 2 | GO_0030728 | |
| Disease | X-24309 measurement | 1.88e-03 | 20 | 95 | 2 | EFO_0800872 | |
| Disease | gut microbiome measurement, bone density | 2.07e-03 | 78 | 95 | 3 | EFO_0003923, EFO_0007874 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 2.27e-03 | 22 | 95 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | gamma-glutamylglutamine measurement | 2.27e-03 | 22 | 95 | 2 | EFO_0021138 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 2.48e-03 | 23 | 95 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 2.48e-03 | 23 | 95 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 2.48e-03 | 23 | 95 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 2.48e-03 | 23 | 95 | 2 | C0014556 | |
| Disease | temperament and character inventory | 2.70e-03 | 24 | 95 | 2 | EFO_0004825 | |
| Disease | Kidney Diseases | 2.91e-03 | 88 | 95 | 3 | C0022658 | |
| Disease | white matter hyperintensity measurement | 2.97e-03 | 302 | 95 | 5 | EFO_0005665 | |
| Disease | brain cancer (implicated_via_orthology) | 3.17e-03 | 26 | 95 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | isthmus cingulate cortex volume measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0010310 | |
| Disease | Endogenous Hyperinsulinism | 3.17e-03 | 26 | 95 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 3.17e-03 | 26 | 95 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 3.17e-03 | 26 | 95 | 2 | C1257965 | |
| Disease | nevus count, cutaneous melanoma | 3.20e-03 | 91 | 95 | 3 | EFO_0000389, EFO_0004632 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGCCSEPYPDVTFTL | 216 | Q9GZZ6 | |
| TEYCNGDLPYCLPDT | 181 | Q6NVV9 | |
| PTETSYVCTCVPGYS | 3106 | P13611 | |
| PFYYGLCTPCQAPTN | 286 | O43505 | |
| SYDCVCSPGYEPVSG | 91 | Q9UHX3 | |
| YLNSCINPIIYPCSS | 316 | P35348 | |
| GSCLPVFSTLPFAYC | 1511 | P53420 | |
| CQPPAYTYNNITCAS | 571 | P35858 | |
| QYECVPYIFVCPGTL | 126 | O95490 | |
| LGYFNSCLNPIIYPC | 336 | P35368 | |
| PTCFILCGNFSSAPY | 316 | P56282 | |
| VKNVISYGCCSEPYP | 211 | Q9UGM1 | |
| SYGCCSEPYPDVTFT | 216 | Q9UGM1 | |
| YPVCLAPYLVVTTCS | 1006 | Q8TDJ6 | |
| PTPSSYRCECNVGYT | 426 | Q75N90 | |
| GSSGTSPPYCCVDLY | 156 | Q9H6U6 | |
| IPSYCLGAYCNSPSA | 746 | Q9Y485 | |
| LIYNASCATCYPPSN | 1246 | O60312 | |
| SCYLPPLRYPATCTF | 66 | P55895 | |
| GQYCDSLYVPCAPSP | 176 | Q7Z3S9 | |
| FYSVPSFPECSSQCG | 636 | P19113 | |
| VYSPQSGFTCVSPCS | 5311 | Q99102 | |
| PYYSCQCAPPFSGSR | 1396 | Q04721 | |
| PSPLNYYNFPKSCCT | 181 | P53582 | |
| SYQCVDTPCPATYRQ | 4926 | Q8NDA2 | |
| YGMVCYSCLLAPPNT | 131 | Q9UNE0 | |
| PCPYGSYSNGSDCTR | 396 | Q6UXG2 | |
| VSCLYTLGYPPAQAQ | 146 | Q96EX3 | |
| YYESPSTQCLLCSSP | 741 | Q12766 | |
| VPGSYQCACPEQGYT | 1001 | P98095 | |
| SYPTCTQCRDSQDPY | 471 | O15031 | |
| SENPCSLYSSVCYSP | 276 | Q8IY47 | |
| YTVVGTPCYISPELC | 161 | Q86SG6 | |
| TTLYLVPCLNDCGPY | 491 | Q9HCN3 | |
| QPCLALLCSPYYSGN | 381 | Q8N594 | |
| VYCQGPTPNCSIYEP | 136 | Q9BZM2 | |
| GQYCDSLYVPCAPSP | 176 | P0DPK4 | |
| YCLYPILESQVCAPS | 161 | A6NFQ7 | |
| YTSECFPCKPGTFSN | 286 | A8MWY0 | |
| SAYPPNGVECYSCVG | 131 | O95274 | |
| CYAPLNPDNTSLYDC | 471 | Q9UHC9 | |
| SRCATLQYCPDPYIQ | 6 | Q9H3D4 | |
| QTDSGPYCVPCYDNT | 21 | Q13643 | |
| PGYCDSSQCASIPYN | 3041 | Q99715 | |
| SYKPICPTCQTSYGI | 591 | Q8TDB6 | |
| GSYYCTCPVGFVLLP | 376 | P01133 | |
| LENSYSCTCPPGFYG | 346 | O00548 | |
| TCRVTYCPTEPGNYI | 2101 | P21333 | |
| NTVSSYFCKCPPGFY | 306 | P35555 | |
| PGYCDPSSCSAYGVR | 1756 | Q05707 | |
| DKIPPSLYSTYCQAC | 611 | O15360 | |
| AYSCSQLPTCGDQVY | 581 | Q9BY84 | |
| PEITVYTSCCYFPSA | 1176 | O75976 | |
| YTSCCYFPSAARLPS | 1181 | O75976 | |
| TITGEYCCSCAPPYR | 76 | Q5JW98 | |
| SYECTTDCPNLQPYF | 16 | P07316 | |
| AGPVDLCTYPKYCTV | 1186 | Q9NSI6 | |
| SCQSPCYRPAYGSTF | 156 | Q52LG2 | |
| YYPTTVCLPGCLNQS | 121 | Q9BYQ4 | |
| YYPTTVCLPGCLNQS | 106 | Q9BYQ2 | |
| YYPTTVCLPGCLNQS | 101 | Q9BYP9 | |
| PCFIPSYVSPLCYIS | 181 | Q3LI83 | |
| SYVSPLCYISNSCQP | 186 | Q3LI83 | |
| NTVGSYFCVCPRGYV | 336 | P35556 | |
| NPCETCPPVNSTEYY | 1616 | P35556 | |
| CPPVNSTEYYTLCPG | 1621 | P35556 | |
| GTCYNTLGNYTCICP | 1706 | P35556 | |
| PTCPGAQLCTVYYAS | 1556 | P49327 | |
| ENCYNTPGSYVCVCP | 306 | Q6UXH1 | |
| SCPCSYPTEVAYSTA | 321 | B1AKI9 | |
| YGCQAPTICFVYQDP | 171 | Q16531 | |
| CKYCPATFYSSPGLT | 471 | Q01101 | |
| SQPYECVFTGTCYPN | 246 | Q4G0U5 | |
| EQYYTFCRPSSCPSL | 161 | Q9NXL9 | |
| PSTCLPNYYRCSSGT | 1416 | Q92673 | |
| YISICGSFPPQSCIF | 41 | A6NC51 | |
| PTEYCGTFCYPNVSQ | 216 | O60502 | |
| FTPSYGVVPCCTSLE | 181 | Q96ME1 | |
| PVYCPASLGSCFAEI | 531 | Q1XH10 | |
| LQYECTACPSGTYKP | 316 | Q4LDE5 | |
| YLQLDPCTCDYPESG | 271 | Q8N9S9 | |
| NDINECTPPYSVYCG | 66 | Q9BY15 | |
| CTPPYSVYCGFNAVC | 71 | Q9BY15 | |
| GYFNSCVNPLIYPCS | 391 | P25100 | |
| SYCTLPPMYPGSSTC | 1236 | Q9NRJ4 | |
| VCSLSHQQPPTSCYY | 111 | Q5GAN3 | |
| TYKGLPCPYASCILA | 141 | A0A1B0GVZ9 | |
| LCYGAPPLLYCGTSS | 1306 | Q96KV7 | |
| YPCDLCGKSYSAPQS | 441 | P0CJ78 | |
| KTEPCISYGCNPLYF | 466 | A4D1E1 | |
| GASPYQCTICTEYCP | 626 | Q05516 | |
| QTTVYCCPYCSFLSP | 976 | Q9C0A1 | |
| LPYCGPNIIDSYFCD | 166 | Q8NGC2 | |
| PPSSYILSNNGYCTV | 331 | P20142 | |
| ISFYQACCLPGVIPY | 281 | Q8NCC5 | |
| ACCLPGVIPYSLAYA | 286 | Q8NCC5 | |
| CRPPDSSYNSLYSTC | 621 | Q8NER1 | |
| IPSGSCPVILNTYFC | 371 | Q14159 | |
| ETPAPNYYNASVSCC | 146 | Q5TH74 | |
| STPYNSIPGSAVCAY | 316 | Q9H2E6 | |
| SGFLPYCEPVYQRCV | 596 | O14787 | |
| CLSSCPSGYYGTRYP | 76 | Q9BXY4 | |
| GINNYTCLCPPEYTG | 1016 | O94813 | |
| PEPGLSQYICYVFQC | 406 | O60343 | |
| QSGFLPYCEPVYQRC | 606 | Q92973 | |
| CYSDTSCPQEDQYPP | 196 | Q8N2W9 | |
| VAPYFSYPVALSCKC | 91 | P01222 | |
| GTPDAFSQLLTCPYC | 161 | P37275 | |
| QTYVKCPAPCQTTYV | 86 | Q5T750 | |
| GASPCQSYYVQAPAS | 136 | Q5T750 | |
| YCVTDPCSAPCSTSY | 156 | Q5T750 | |
| EVYSCPYCTNSPIFG | 561 | Q2M1K9 | |
| VPEGLCISVPCSFSY | 31 | Q96LC7 | |
| CPAYSSYTNCLPSCS | 2211 | Q9Y493 | |
| VGAPSVCSSCGQSYY | 341 | Q6DD87 |